ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,332Medicare Part D Prescriptions Filled, Including Refills

Rank: 155 out of 2343

$980K Total Retail Price of All Prescriptions

Rank: 136 out of 2343

540 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 540 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 540 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 15,559 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 662 649 1 2
OMEPRAZOLE 551 536 2 4
FUROSEMIDE 531 512 3 6
SIMVASTATIN 476 431 4 1
ATENOLOL 419 386 5 12
METOPROLOL SUCCINATE 304 283 6 14
GLIMEPIRIDE 299 280 7 45
SPIRONOLACTONE 286 275 8 65
AMLODIPINE BESYLATE 284 284 9 5
LISINOPRIL 248 230 10 3
MIRTAZAPINE 226 226 11 41
CITALOPRAM HBR 224 222 12 17
SERTRALINE HCL 213 210 13 20
JANTOVEN 212 212 14 81
ATORVASTATIN CALCIUM 206 197 15 10
POLYETHYLENE GLYCOL 3350 205 205 16 54
ESCITALOPRAM OXALATE 200 200 17 55
NAMENDA 199 199 18 36
DONEPEZIL HCL 199 189 18 21
RAMIPRIL 181 176 20 90
FLUTICASONE PROPIONATE 180 173 21 46
TRAZODONE HCL 162 147 22 53
GABAPENTIN 154 141 23 16
ZOLPIDEM TARTRATE 154 133 23 24
CLOPIDOGREL 153 146 25 26
CARVEDILOL 136 136 26 27
ALENDRONATE SODIUM 134 130 27 28
LOSARTAN POTASSIUM 129 125 28 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 125 28 42
METFORMIN HCL ER 124 102 30 88
PANTOPRAZOLE SODIUM 122 122 31 22
VOLTAREN 119 118 32 175
PRAVASTATIN SODIUM 115 103 33 15
TRAMADOL HCL 114 112 34 25
ADVAIR DISKUS 113 112 35 34
QUETIAPINE FUMARATE 111 111 36 77
FENTANYL 110 110 S2 37 69
NEXIUM 110 101 37 33
SPIRONOLACTONE-HCTZ 106 106 39 278
WARFARIN SODIUM 105 97 40 8
ROPINIROLE HCL 101 99 41 124
METOPROLOL TARTRATE 100 99 42 7
AZITHROMYCIN 94 91 43 39
PLAVIX 92 90 44 38
CYMBALTA 92 87 44 74
HYDROCODONE-ACETAMINOPHEN 89 89 S3 46 13
CARBIDOPA-LEVODOPA 85 85 47 85
DIGOXIN 85 85 47 35
RISPERIDONE 84 72 49 61
AMLODIPINE BESYLATE-BENAZEPRIL 84 84 49 59
NYSTATIN-TRIAMCINOLONE 78 78 51 249
VITAMIN D2 78 78 51 369
ATENOLOL-CHLORTHALIDONE 77 70 53 190
LIPITOR 77 77 53 78
METFORMIN HCL 76 76 55 9
LACTULOSE 76 76 55 139
LIDODERM 75 75 57 130
BYSTOLIC 75 75 57 123
LEVOXYL 74 73 59 237
FAMOTIDINE 73 73 60 60
BENICAR HCT 73 73 60 156
IPRATROPIUM-ALBUTEROL 73 73 60 99
ISOSORBIDE MONONITRATE ER 72 72 63 32
VENLAFAXINE HCL ER 70 44 64 87
EXELON 70 70 64 129
LANTUS 70 60 64 51
LOSARTAN-HYDROCHLOROTHIAZIDE 69 64 67 64
HYDROCHLOROTHIAZIDE 68 65 68 11
POTASSIUM CHLORIDE 66 64 69 18
TRICOR 65 65 70 96
CLOTRIMAZOLE-BETAMETHASONE 64 60 71 127
OXYCODONE HCL 64 61 S2 71 67
AZOR 64 64 71 262
MECLIZINE HCL 63 63 74 103
SPIRIVA 62 61 75 48
HYDROCORTISONE 62 62 75 225
CRESTOR 59 59 77 30
MELOXICAM 58 55 78 68
SYNTHROID 54 52 79 40
PREDNISONE 52 41 80 37
OXYCONTIN 51 49 S2 81 138
OLANZAPINE 51 51 81 121
KLOR-CON M20 50 50 83 44
BISOPROLOL-HYDROCHLOROTHIAZIDE 50 50 83 151
PAROXETINE HCL 50 48 83 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.